Antipyretic therapy in febrile critically ill adults: A systematic review and meta-analysis

Journal of Critical Care

Volumn 28, Issue 3, 2013, Pages 303-310

  Niven, Daniel J ^a   Stelfox, H Tom ^a   Laupland, Kevin B ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

Antipyretic; Critical illness; Fever; ICU; Mortality

Indexed keywords

ANTIPYRETIC AGENT; IBUPROFEN; PARACETAMOL;

ARTICLE; CHEMOTHERAPY; CONTROLLED STUDY; CRITICALLY ILL PATIENT; DATA ANALYSIS; DISEASE ASSOCIATION; DRUG EFFICACY; FEVER; HUMAN; INDUCED HYPOTHERMIA; INTENSIVE CARE UNIT; INTERVENTION STUDY; MAJOR CLINICAL STUDY; META ANALYSIS; MORTALITY; NEUROLOGIC DISEASE; PERCEPTIVE THRESHOLD; PHYSIOTHERAPY; RANDOMIZED CONTROLLED TRIAL; SINGLE DRUG DOSE; SYSTEMATIC REVIEW; TEMPERATURE MEASUREMENT; TREATMENT RESPONSE;

ADULT; ANTIPYRETICS; CRITICAL ILLNESS; FEVER; HOSPITAL MORTALITY; HUMANS; HYPOTHERMIA, INDUCED;

EID: 84876858063     PISSN: 08839441     EISSN: 15578615     Source Type: Journal    
DOI: 10.1016/j.jcrc.2012.09.009     Document Type: Article

References (32)

1. Laupland K.B., Shahpori R., Kirkpatrick A.W., et al. Occurrence and outcome of fever in critically ill adults. Crit Care Med 2008, 36:1531-1535.
2. Ryan M., Levy M.M. Clinical review: fever in intensive care unit patients. Crit Care 2003, 7:221-225.
3. O'Grady N.P., Barie P.S., Bartlett J.G., et al. Guidelines for evaluation of new fever in critically ill adult patients: 2008 update from the American College of Critical Care Medicine and the Infectious Diseases Society of America. Crit Care Med 2008, 36:1330-1349.
4. Barie P.S., Hydo L.J., Eachempati S.R. Causes and consequences of fever complicating critical surgical illness. Surg Infect 2004, 5:145-159.
5. Young P.J., Saxena M., Beasley R., et al. Early peak temperature and mortality in critically ill patients with or without infection. Intensive Care Med 2012, 38:437-444.
6. Lee B.H., Inui D., Suh G.Y., et al. Association of body temperature and antipyretic treatments with mortality of critically ill patients with and without sepsis: multi-centered prospective observational study. Crit Care 2012, 16:R33.
7. Niven D.J., Shahpori R., Stelfox H.T., et al. Management of febrile critically ill adults: a retrospective assessment of regional practice. Therapeutic Hypothermia and Temperature Management 2011, 1:99-104.
8. Boyle M., Hundy S., Torda T.A. Paracetamol administration is associated with hypotension in the critically ill. Aust Crit Care 1997, 10:120-122.
9. Watkins P.B., Kaplowitz N., Slattery J.T., et al. Aminotransferase elevations in healthy adults receiving 4 grams of acetaminophen daily: a randomized controlled trial. JAMA 2006, 296:87-93.
10. Laupland K.B., Zahar J.R., Adrie C., et al. Determinants of temperature abnormalities and influence on outcome of critical illness. Crit Care Med 2012, 40:145-151.
11. Gozzoli V., Schöttker P., Suter P.M., et al. Is it worth treating fever in intensive care unit patients? Preliminary results from a randomized trial of the effect of external cooling. Arch Intern Med 2001, 161:121-123.
12. Schulman C.I., Namias N., Doherty J., et al. The effect of antipyretic therapy upon outcomes in critically ill patients: a randomized, prospective study. Surg Infect 2006, 6:369-375.
13. Morris P.E., Promes J.T., Guntupalli K.K., et al. A multi-center, randomized, double-blind, parallel, placebo-controlled trial to evaluate the efficacy, safety, and pharmacokinetics of intravenous ibuprofen for the treatment of fever in critically ill and non-critically ill adults. Crit Care 2010, 14:R125.
14. Hammond N.E., Boyle M. Pharmacological versus non-pharmacological antipyretic treatments in febrile critically ill adult patients: a systematic review and meta-analysis. Aust Crit Care 2011, 24:4-17.
15. Jefferies S., Weatherall M., Young P., et al. The effect of antipyretic medications on mortality in critically ill patients with infection: a systematic review and meta-analysis. Crit Care Resusc 2011, 13:125-131.
16. Schortgen F., Clabault K., Katsahian S., et al. Fever control using external cooling in septic shock: a randomized controlled trial. Am J Respir Crit Care Med 2012, 185:1088-1095.
17. Niven D.J., Stelfox H.T., Leger C., et al. Assessment of the safety and feasibility of administering anti-pyretic therapy in critically ill adults: a pilot randomized clinical trial. J Crit Care 2013, 28:296-302.
18. Liberati A., Altman D.G., Tetzlaff J., et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol 2009, 62:e1-e34.
19. Higgins J.P.T., Green S. Cochrane Handbook for Systematic Reviews of Interventions version 5.1.0, updated March 2011. The Cochrane Collaboration 2011 Available at, Accessed 14 April 2012. http://www.cochranehandbook.org.
20. Laupland K.B. Fever in the critically ill medical patient. Crit Care Med 2009, 37:S273-S278.
21. Niven D.J., Leger C., Stelfox H.T., et al. Fever in the critically ill: a review of epidemiology, immunology, and management. J Intensive Care Med 2012, 27:299-306.
22. Egger M. Davey Smith G, Schneider M, et al.: Bias in meta-analysis detected by a simple, graphical test. BMJ 1997, 315:629-634.
23. Higgins J.P., Thompson S.G. Quantifying heterogeneity in a meta-analysis. Stat Med 2002, 21:1539-1558.
24. DerSimonian R., Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986, 7:177-188.
25. Bernard G.R., Wheeler A.P., Russell J.A., et al. The effects of ibuprofen on the physiology and survival of patients with sepsis. The Ibuprofen in Sepsis Study Group. N Engl J Med 1997, 336:912-918.
26. Cunha B.A., Digamon-Beltran M., Gobbo P.N. Implications of fever in the critical care setting. Heart Lung 1984, 13:460-465.
27. Haupt M.T., Jastremski M.S., Clemmer T.P., Metz C.A., Goris G.B. Effect of ibuprofen in patients with severe sepsis: a randomized, double-blind, multicenter study. The Ibuprofen Study Group. Crit Care Med 1991, 19:1339-1347.
28. Arons M.M., Wheeler A.P., Bernard G.R., et al. Effects of ibuprofen on the physiology and survival of hypothermic sepsis. Ibuprofen in Sepsis Study Group. Crit Care Med 1999, 27:699-707.
29. Henker R., Rogers S., Kramer D.J., et al. Comparison of fever treatments in the critically ill: a pilot study. Am J Crit Care 2001, 10:276-280.
30. Cruz P., Garutti I., Diaz S., et al. Metamizol versus propacetamol: comparative study of the hemodynamic and antipyretic effects in critically ill patients. Rev Esp Anaestesiol Reanim 2002, 49:391-396.
31. Gozzoli V., Treggiari M.M., Kleger G.R., et al. Randomized trial of the effect of antipyresis by metamizol, propacetamol or external cooling on metabolism, hemodynamics and inflammatory response. Intensive Care Med 2004, 30:401-407.
32. Memis D., Karamanlioglu B., Turan A., et al. Effects of lornoxicam on the physiology of severe sepsis. Crit Care 2004, 8:R474-R482.